Review article: Gastrointestinal amyloidosis - Clinical features, diagnosis and therapy

Alimentary Pharmacology and Therapeutics

Volumn 27, Issue 11, 2008, Pages 1006-1016

  Petre, S ^a   Shah, I A ^a   Gilani, N ^a  

^a CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; CISAPRIDE; COLCHICINE; CORTICOSTEROID; DEXAMETHASONE; DOMPERIDONE; DOXORUBICIN; LOPERAMIDE; MELPHALAN; METOCLOPRAMIDE; NEOSTIGMINE; OCTREOTIDE; ONDANSETRON; PREDNISONE; PROCHLORPERAZINE; PROKINETIC AGENT; PROMETHAZINE; VINCRISTINE;

ABDOMINAL PAIN; AMYLOIDOSIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL FEATURE; DIARRHEA; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HEPATOMEGALY; HUMAN; INTESTINAL DYSMOTILITY; LEUKEMIA; LIVER TRANSPLANTATION; PATHOGENESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW;

AMYLOIDOSIS; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HUMANS; LIVER TRANSPLANTATION; STEROIDS; TRANSPLANTATION, AUTOLOGOUS;

EID: 42949176074     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2008.03682.x     Document Type: Review

References (86)

1. Glenner GG. Amyloid deposits and amyloidosis. The β-fibrilloses. N Engl J Med 1980 302 : 1283 92.
2. Gertz MA, Kyle RA. Hepatic amyloidosis: clinical appraisal in 77 patients. Hepatology 1997 25 : 118 21.
3. Comenzo RL, Vosburgh E, Simms RW, et al. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients. Blood 1996 88 : 2801 6.
4. Gillmore JD, Lovat LB, Hawkins PN. Amyloidosis and the liver. J Hepatol 1999 30 : 17 33.
5. Husby G. Nomenclature and classification of amyloid and amyloidoses. J Intern Med 1992 232 : 511 20.
6. Yoshimatsu S, Ando Y, Terazaki H, et al. Endoscopic and pathological manifestations of the gastrointestinal tract in familial amyloidotic polyneuropathy type I (Met30). J Intern Med 1998 243 : 65 72.
7. Jaakkola H, Tornroth T, Groop PH, Honkanen E. Renal failure and nephrotic syndrome associated with gastrointestinal stromal tumour (GIST) - a rare cause of AA amyloidosis. Nephrol Dial Transplant 2001 16 : 1517 8.
8. Kuang L, Sun W, Gibson MF, Sanusi D. Gastrointestinal amyloidosis with ulceration, hemorrhage, small bowel diverticula, and perforation. Dig Dis Sci 2003 48 : 2023 6.
9. Friedman S, Janowitz H. Systemic amyloidosis and the gastrointestinal tract. Gastroenterol Clin North Am 1998 27 : 595 614.
10. Greenstein AJ, Sachar DB, Panday AK, et al. Amyloidosis and inflammatory bowel disease: a 50 year experience with 25 patients. Medicine 1992 71 : 261 70.
11. Werther JL, Schapira A, Rubinstein O, Janowitz HD. Amyloidosis in regional enteritis. A report of five cases. Am J Med 1960 40 : 416 23.
12. Dave SP, Greenstein AJ, Sachar DV, Herpaz N, Aledort L. Bleeding diathesis in amyloidosis with renal insufficiency associated with Crohn's disease: response to desmopressin. Am J Gastroenterol 2002 97 : 187 9.
13. Levy M, Polliack A, Lender M, Eliakim M. The liver in amyloidosis. Digestion 1974 10 : 40 51.
14. Gertz MA, Lacy MQ, Dispenzieri A. Amyloidosis. Hematol Oncol Clin North Am 1999 13 : 1211 33.
15. Buxbaum JN. The amyloid diseases. In : Wyngaarden JB, Smith LH Jr., Bennett JC, eds. Cecil Textbook of Medicine, 19th edn. Philadelphia : WB Saunders, 1992 : 1144.
16. Gertz MA, Li CY, Shirahama T, Kyle RA. Utility of subcutaneous fat aspiration for the diagnosis of systemic amyloidosis. Arch Intern Med 1988 148 : 929 33.
17. Poullos PD, Stollman N. Gastrointestinal amyloidosis: approach to treatment. Curr Treat Options Gastroenterol 2003 6 : 17 25.
18. Chinnakotla AK, DeLuna AM, Thew ST, Anderson BR, Cantave IM. Symptomatic gastrointestinal amyloidosis in an HIV-infected patient. Am J Gastroenterol 2001 96 : 2248 50.
19. Chang SS, Lu CL, Tsay SH, Chang FY, Lee SD. Amyloidosis-induced gastrointestinal bleeding in a patient with multiple myeloma. J Clin Gastroenterol 2001 32 : 161 3.
20. Browning MJ, Banks RA, Tribe CR, et al. Ten years experience in an amyloid clinic: a clinicopathologic survery. Q J Med 1985 54 : 213 27.
21. Floege J, Ketteler M. beta2-microglobulin-derived amyloidosis: an update. Kidney Int Suppl 2001 78 : S164 71.
22. Jimenez RE, Price DA, Pinkus GS, et al. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis. Am J Surg Pathol 1998 22 : 729 35.
23. Dulgheru EC, Balos LL, Baer AN. Gastrointestinal complications of beta2-microglobulin amyloidosis: a case report and review of the literature. Arthritis Rheum 2005 53 : 142 5.
24. Hawkins PN. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo. Clin Sci 1994 87 : 289 95.
25. Hawkins PN, Richardson S, MacSweeney JE, et al. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression. Q J Med 1993 86 : 365 74.
26. Merlini G. Treatment of primary amyloidosis. Semin Hematol 1995 32 : 60 79.
27. Tada S, Iida M, Iwashita A, et al. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc 1990 36 : 10 4.
28. Brandt K, Cathcart ES, Cohen AS. A clinical analysis of the course and prognosis of forty-two patients with amyloidosis. Am J Med 1968 44 : 955 69.
29. Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M. Significance of SAA 1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology 2006 45 : 43 9.
30. Menke DM, Kyle RA, Fleming CR, Wolfe JT 3rd., Kurtin PJ, Oldenburg WA. Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin Proc 1993 68 : 763 7.
31. Gertz MA, Kyle RA. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients. Am J Med 1988 85 : 73 80.
32. Usui M, Matsuda S, Suzuki H, Hirata K, Ogura Y, Shiraishi T. Gastric amyloidosis with massive bleeding requiring emergency surgery. J Gastroenterol 2000 35 : 924 8.
33. Levine RA. Amyloid disease of the liver. Correlation of clinical, functional and morphologic features in forty-seven patients. Am J Med 1962 33 : 349 57.
34. Okuda Y, Takasugi K, Oyama T, Oyama H, Nanba S, Miyamoto T. Intractable diarrhea associated with secondary amyloidosis in rheumatoid arthritis. Ann Rheum Dis 1997 56 : 535 41.
35. Battle WM, Rubin MR, Cohen S, Snape WJ. Gastrointestinal motility dysfunction in amyloidosis. N Engl J Med 1979 301 : 24 5.
36. Malagelada JR, Camilleri M, Stanghallini V. Manometric Diagnosis of Gastrointestinal Motility Disorders. New York : Thieme, 1986 : I II.
37. Tada S, Iida M, Yao T, Kitamoto T, Yao T, Fujishima M. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. Gut 1993 34 : 1412 7.
38. Guirl MJ, Hogenauer C, Santa Ana CA, et al. Rapid intestinal transit as a primary cause of severe chronic diarrhea in patients with amyloidosis. Am J Gastroenterol 2003 98 : 2219 25.
39. Grazi GL, Cescon M, Salvi F, et al. Combined heart and liver transplantation for familial amyloidotic neuropathy: considerations from the hepatic point of view. Liver Transpl 2003 9 : 986 92.
40. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. NEJM 1999 341 : 137 41.
41. Feurle FE. Pathophysiology of diarrhea in patients with familial amyloid neuropathy. Digestion 1987 36 : 13 7.
42. Chang HS, Myung SJ, Yang SK, et al. Massive small bowel bleeding in a patient with amyloidosis. Gastrointest Endosc 2004 59 : 126 9.
43. Hayman SR, Lacy MQ, Kyle RA, Gertz MA. Primary systemic amyloidosis: a cause of malabsorption syndrome. Am J Med 2001 111 : 535 40.
44. Buck FS, Koss MN. Hepatic amyloidosis: morphologic differences between systemic AL and AA types. Hum Pathol 1991 22 : 904 7.
45. Breedveld FC, Markusse HM, MacFarlane JD. Subcutaneous fat biopsy in the diagnosis of amyloidosis secondary to chronic arthritis. Clin Exp Rheumatol 1989 7 : 407 10.
46. Youssef N, Carbonell N, Bonte H, Serfaty L, Poupon R, Flejou JF. Fatal Dieulafoy's type ulcer in a case of gastric AL-amyloidosis. Ann Pathol 2004 24 : 256 8.
47. Hong WS, Kim JH, Min YI, et al. Massive small bowel bleeding in a patient with amyloidosis. Gastrointest Endosc 2004 59 : 126 9.
48. Kapp JP. Hepatic amyloidosis with portal hypertension. JAMA 1965 191 : 497 9.
49. Serra L, Poppi MC, Criscuolo M, Zandomeneghi R. Primary systemic amyloidosis with giant hepatomegaly and portal hypertension: a case report and a review of the literature. Ital J Gastroenterol 1993 25 : 435 8.
50. Zeijen RN, Sels JP, Flendrig JA, Arends JW. Portal hypertension and intrahepatic cholestasis in hepatic amyloidosis. Neth J Med 1991 38 : 257 61.
51. Levy M, Fryd CH, Eliakim M. Intrahepatic obstructive jaundice due to amyloidosis of the liver. A case report and review of the literature. Gastroenterology 1971 61 : 234 8.
52. Boggio L, Green D. Recombinant human factor VIIa in the management of amyloid associated factor X deficiency. Br J Haematol 2001 112 : 1074 5.
53. Kowdley KV, Setrakian S, Lopategui J, Johnson DE, Arora S. Hepatic and pancreatic involvement in systemic amyloidosis. Am J Gastroenterol 1993 88 : 1440 1.
54. Kim SH, Han JK, Lee KH, et al. Abdominal amyloidosis: spectrum of radiological findings. Clin Radiol 2003 58 : 610 20.
55. Bighi S, Trevisani L, Lupi L, Ariutti R, Cervi PM, Liboni A. Amyloidosis of the gastric stump: radiographic and CT findings. Gastrointest Radiol 1990 15 : 197 8.
56. Araoz PA, Batts KP, MacCarty RL. Amyloidosis of the alimentary canal: radiologic pathologic correlation of CT findings. Abdom Imaging 2000 25 : 38 44.
57. Suzuki C, Higaki S, Nishiaki M, et al. 99mTc-HSA-D scintigraphy in the diagnosis of protein-losing gastroenteropathy due to secondary amyloidosis. J Gastroenterol 1997 32 : 78 82.
58. Fushimi T, Takahashi Y, Kashima Y, et al. Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid 2005 12 : 48 53.
59. Tada S, Iida M, Yao T, et al. Gastrointestinal amyloidosis: radiologic features by chemical types. Radiology 1994 190 : 37 42.
60. Camilleri M, Malagelada JR, Stanghellini V, Fealey RD, Sheps SG. Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology 1985 88 : 1852 9.
61. Araki H, Muramoto H, Oda K, et al. Severe gastrointestinal complications of dialysis-related amyloidosis in two patients on long-term hemodialysis. Am J Nephrol 1996 16 : 149 53.
62. Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine 2003 82 : 291 8.
63. Greipp PR, Kyle RA, Bowie EJ. Factor X deficiency in primary amyloidosis: resolution after splenectomy. NEJM 1979 301 : 1050 1.
64. Okuda Y, Takasugi K, Oyama T, Onuma M, Oyama H. Amyloidosis in rheumatoid arthritis - clinical study of 124 histologically proven cases (abstract in English). Ryumachi 1994 34 : 939 46.
65. Delgado AW, Mosqueda A. A highly sensitive method for diagnosis of secondary amyloidosis by labial salivary gland biopsy. J Oral Pathol Med 1989 18 : 310 4.
66. Yamada M, Hatakeyama S, Tsukagoshi H. Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy. Hum Pathol 1985 16 : 1206 11.
67. Chopra S, Rubinow A, Koff RS, Cohen AS. Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms. Am J Pathol 1984 115 : 186 93.
68. Looi LM, Sumithran E. Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis. Hum Pathol 1988 19 : 732 5.
69. Sasaki M, Nakanuma Y, Terada T, et al. Amyloid deposition in intrahepatic large bile ducts and peribiliary glands in systemic amyloidosis. Hepatology 1990 12 : 743 6.
70. Garcia-Tsao G, Boyer JL. Outpatient liver biopsy: how safe is it? Ann Intern Med 1993 118 : 150 3.
71. Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962 10 : 355 64.
72. Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine 1975 54 : 271 99.
73. Jacobs P, Sellars S, King HS. Massive macroglossia, amyloidosis and myeloma. Postgrad Med J 1988 64 : 696 8.
74. Costigan DJ, Clouse RE. Achalasia-like esophagus from amyloidosis. Successful treatment with pneumatic bag dilatation. Dig Dis Sci 1983 28 : 763 5.
75. Reddy AB, Wright RA, Wheeler GE, Nazer H. Nonobstructive gastroparesis in amyloidosis improved with metoclopramide. Arch Intern Med 1983 143 : 247 8.
76. Gil R, Debiais F, Lefevre FP, et al. Amyloidosis with gastroparesis. Improvement with domperidone. Presse Med 1984 13 : 564.
77. Van Thiel DH, Nadir A, Hassanein T, Wright HI. Simultaneous right-sided volume overload and left-sided hypovolemia in a man with massive ascites and a hydrothorax. Am J Gastroenterol 1995 90 : 478 81.
78. Dhodapkar MV, Jagannath S, Vesole D, et al. Treatment of AL-amyloidosis with dexamethasone plus alpha interferon. Leuk Lymphoma 1997 27 : 351 6.
79. Gertz MA, Kyle RA. Acute leukemia and cytogenetic abnormalities complicating melphalan treatment of primary systemic amylodosis. Arch Intern Med 1990 150 : 629 33.
80. Gertz MA, Lacy MQ, Dispenzieri A. Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report. Bone Marrow Transplant 2000 25 : 465 70.
81. Suhr OB, Holmgren G, Steen L, et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995 60 : 933 8.
82. Holmgren G, Steen L, Ekstedt J, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991 40 : 242 6.
83. Hawkins PN, Persey MR, Lovat LB, et al. UK experience of liver transplantation in FAP. Neuromuscul Disord 1996 6 : S77.
84. Nardo B, Beltempo P, Bertelli R, et al. Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center. Transplant Proc 2004 36 : 645 7.
85. Martinez-Vea A, Garcia C, Carreras M, Revert l, Oliver JA. End-stage renal disease in systemic amyloidosis: clinical course and outcome on dialysis. Am J Nephol 1990 10 : 283 9.
86. Hosenpud JD, DeMarco T, Frazier OH, et al. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Circulation 1991 84 : III338 43.